Grifols SA
Grifols SA is a Healthcare company operating in Drug Manufacturers - General with a $4.95B market cap.
Behavioral analysis
Disclosures
Transcripts
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Spoken Alpha tracks GRFS's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 100% of the time
SamplePeers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for GRFS.
$ curl https://api.spokenalpha.com/v1/companies/GRFSFAQ
Spoken Alpha indexes GRFS's earnings call transcripts at https://spokenalpha.com/companies/GRFS. Each call links to attributed speakers and parsed analyst Q&A.
Grifols SA (GRFS) operates in the Healthcare sector (Drug Manufacturers - General industry).
When a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.81 | $3.14 | +21.4% | -8.4% | -8.2% |
| Q4 FY2026 | $4.03 | $3.22 | +25.0% | -6.0% | -9.0% |
| Q3 FY2026 | $3.49 | $3.16 | +10.6% | -2.2% | -1.8% |
| Q2 FY2026 | $3.69 | $3.31 | +11.6% | -8.6% | -10.0% |
| Q1 FY2025 | $3.59 | $3.27 | +9.9% | -7.7% | -10.0% |
| Q4 FY2025 |
| $3.60 |
| $3.28 |
| +9.8% |
| -4.1% |
| -2.0% |
| Q3 FY2025 | $3.84 | $3.13 | +22.8% | -9.8% | -8.4% |
| Q2 FY2025 | $3.94 | $3.31 | +19.0% | -8.8% | -8.0% |
| Q1 FY2024 | $4.16 | $3.41 | +22.0% | -6.0% | -4.9% |
| Q4 FY2024 | $3.89 | $3.17 | +22.8% | -8.3% | -7.4% |